| Company name | Leven Vision |
| Year of establishment | 2024 |
| Sector | Life Sciences & Health |
| Website | |
| Status | Active |
Leven Vision
Leven Vision is a Leiden company building AI-powered microscopy that automates detection of parasitic infections in stool samples and other lab diagnostics. Working with partners such as Erasmus MC, it reduces manual slide reading while improving sensitivity and speed, supporting better clinical decision-making worldwide.
This investment is managed by
Bart Hoenen, Investment Manger (LEH) at UNIIQ.



